A/Prof Hayley Newton
Honorary (Principal Fellow)
Department of Microbiology and Immunology
86 Scholarly works
12 Projects
HIGHLIGHTS
2026
Journal article
Opsonization Improves Dual Proteomic Analysis of Burkholderia cenocepacia Infections
DOI: 10.1021/acs.jproteome.6c000722026
Journal article
Cytosolic delivery of bacterial metabolites by riboflavin transporters promotes MR1 antigen presentation and MAIT cell recognition
DOI: 10.1111/imcb.701302026
Journal article
Systematic discovery of pathogen effector functions across human pathogens and pathways.
DOI: 10.1016/j.cell.2026.06.0172026
Journal article
Intralysosomal pathogens differentially influence the proteolytic potential of their niche
DOI: 10.1128/iai.00270-252022
Research Grant
Coxiella Pathogenesis and Effector-Effector Interplay
2018
Research Grant
Mitochondria: A Target for Intracellular Bacterial Pathogens.
2017
Research Grant
Manipulation of Clathrin-Mediated Trafficking by Coxiella
RECENT SCHOLARLY WORKS
2025
Journal article
Legionella effector LpPIP recruits protein phosphatase 1 to the mitochondria to induce dephosphorylation of outer membrane proteins
DOI: 10.1371/journal.pbio.30032612025
Journal article
The complete genome sequence of the crayfish pathogen Candidatus Paracoxiella cheracis n.g. n.sp. provides insight into pathogenesis and the phylogeny of the Coxiellaceae family
DOI: 10.1128/msphere.01002-242025
Journal article
Coxiella burnetii manipulates the lysosomal protease cathepsin B to facilitate intracellular success
DOI: 10.1038/s41467-025-59283-32024
Journal article
Genomic epidemiology and phenotypic characterisation of Salmonella enterica serovar Panama in Victoria, Australia
DOI: 10.1371/journal.pntd.00126662024
Journal article
Coxiella burnetii protein CBU2016 supports CCV expansion
DOI: 10.1093/femspd/ftae0182023
Journal article
Eat, prey, love: Pathogen-mediated subversion of lysosomal biology
DOI: 10.1016/j.coi.2023.102344
RECENT PROJECTS
2018
Research Grant
Mitochondria: A Target for Intracellular Bacterial Pathogens.
2017
Research Contracts
Pharmaceutical Development of Antivirulence Compounds Against BW Pathogens